Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ctDNA Monitoring”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06717295
What this trial is testing

The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling

Who this might be right for
Brest CancerLung Cancer (NSCLC)Pancreatic Cancer, Adult+5 more
Javier Toledo 6,000
Not applicableLooking for participantsNCT07001085
What this trial is testing

CtDNA Monitoring in Patients With HCC and mCRC

Who this might be right for
HCC - Hepatocellular CarcinomaColorectal Cancer Metastatic
Medical University of Warsaw 300
Not applicableNot Yet RecruitingNCT06283875
What this trial is testing

The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer

Who this might be right for
Ovarian Cancer
Geneplus-Beijing Co. Ltd. 80
Testing effectiveness (Phase 2)UnknownNCT03957564
What this trial is testing

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

Who this might be right for
Gastric CancerGastro-oesophageal Junction Cancer
Affiliated Hospital of Qinghai University 40
Not applicableLooking for participantsNCT07057102
What this trial is testing

Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Not applicableStudy completedNCT05630131
What this trial is testing

CtDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

Who this might be right for
Bladder CancerMuscle-Invasive Bladder Carcinoma
UNC Lineberger Comprehensive Cancer Center 1
Not applicableLooking for participantsNCT06157060
What this trial is testing

Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA

Who this might be right for
Hepatocellular Carcinoma Resectable
Zhujiang Hospital 255
Large-scale testing (Phase 3)Active Not RecruitingNCT06939439
What this trial is testing

Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer

Who this might be right for
Gastric Cancer Stage III
The First Affiliated Hospital with Nanjing Medical University 416
Not applicableNot Yet RecruitingNCT07597252
What this trial is testing

CtDNA Monitoring After Pancreatic Cancer Surgery (K-4CARE Lite Study)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)NGS Monitor MRD
Chang Gung Memorial Hospital 30
Not applicableNot Yet RecruitingNCT06287593
What this trial is testing

The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC

Who this might be right for
EGF-R Positive Non-Small Cell Lung Cancer
Zhejiang University 300
Testing effectiveness (Phase 2)Looking for participantsNCT04768426
What this trial is testing

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerBreast Cancer
Stanford University 40
Not applicableLooking for participantsNCT07516678
What this trial is testing

Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma

Who this might be right for
Neuroblastoma
Sun Yat-sen University 200
Not applicableUnknownNCT03634826
What this trial is testing

Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).

Who this might be right for
CarcinomaLung CancerNSCLC+1 more
Peking University People's Hospital 200
Not applicableLooking for participantsNCT05446545
What this trial is testing

Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fudan University 139
Not applicableLooking for participantsNCT05778253
What this trial is testing

The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC

Who this might be right for
Lung Squamous Cell Carcinoma
Second Xiangya Hospital of Central South University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06902012
What this trial is testing

Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma

Who this might be right for
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Zhujiang Hospital 15
Not applicableUnknownNCT05513144
What this trial is testing

Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer

Who this might be right for
Gastric CancerCirculating Tumor DNA (ctDNA)
chenwu 30
Not applicableLooking for participantsNCT05889247
What this trial is testing

Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Zealand University Hospital 350
Not applicableLooking for participantsNCT06198868
What this trial is testing

MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Jiangsu Cancer Institute & Hospital 60
Not applicableUnknownNCT05116579
What this trial is testing

Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Sun Yat-sen University 30
Next Page